Forton Daniel, Weissenborn Karin, Bondin Mark, Cacoub Patrice
Department of Gastroenterology and Hepatology, St George's Hospital London, London, UK.
St George's University of London, London, UK.
Antivir Ther. 2018;23(Suppl 2):47-55. doi: 10.3851/IMP3245.
Neurological manifestations of HCV infection appear to be under-recognized in clinical practice despite the majority of HCV-infected patients experiencing symptoms such as fatigue, depression and cognitive dysfunction. There is also growing evidence for a link between HCV infection and an increased risk of Parkinson's disease. The mechanism underpinning the association between HCV and these neuropsychiatric syndromes still requires further investigation. Here we review the pre-clinical and clinical evidence for a link between HCV and effects on the central nervous system leading to neuropsychiatric syndromes. Lastly, we describe how improvements in neuropsychiatric manifestations of HCV following treatment have been observed, which is subsequently reflected in an overall improvement in health-related quality of life.
尽管大多数丙型肝炎病毒(HCV)感染患者会出现疲劳、抑郁和认知功能障碍等症状,但在临床实践中,HCV感染的神经学表现似乎未得到充分认识。越来越多的证据表明,HCV感染与帕金森病风险增加之间存在联系。HCV与这些神经精神综合征之间关联的潜在机制仍需进一步研究。在此,我们综述了HCV与导致神经精神综合征的中枢神经系统影响之间联系的临床前和临床证据。最后,我们描述了如何观察到治疗后HCV神经精神表现的改善,这随后反映在与健康相关的生活质量的整体改善上。